Skin Microbial Ecology in Atopic Dermatitis
University of Rochester · NCT04170244
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 13+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 240
- US sites recruiting
- 1
- Study start
- April 17, 2019
- Record last updated
- July 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema (or atopic dermatitis [AD]) have much higher concentrations of a certain bacteria (S. aureus), especially when their disease is active but little is known about the role that this bacteria plays in psoriasis (i.e. disease severity, biomarkers and skin barrier function). The overarching purpose of this longitudinal study is to understand how the abundance of skin S. aureus (and several commensal bacteria) change as a consequence of standard of care treatment in the URMC dermatology clinics. Other assays and biospecimens will also be collected to address a number of questions.
Being studied: AD subject visit sampling procedures; PS subject visit sampling procedures; Healthy control visit sampling procedures
Conditions: Atopic Dermatitis; Psoriasis; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- ≥13 to 65 years of age (inclusive) for PS, ≥13 for AD and NA, male or female
- Optional Bx sub study - only adults (18-65 yrs; inclusive only)
- Able to understand protocol and give consent
- Able to keep clinic/study appointments and comply with study related procedures
- Must be able to read, speak, and understand English
- Chronic AD, according to the American Academy of Dermatology (AAD) Consensus Criteria (Eichenfield 2014), that has been present for at least 1 year before the enrollment visit
- Chronic PS, according to the AAD Consensus Criteria (Menter et al 2008 (section 1)), that has been present for at least 1 year before the enrollment visit.
- AD subjects: have active lesions on upper extremities, lower extremities, or trunk and a total disease severity of high moderate-to-severe (EASI ≥12)
- PS subjects: have active lesions on upper extremities, lower extremities, or trunk and a total disease severity of high moderate-to-severe (PASI ≥7)
Exclusion Criteria
- Unwilling and/or unable to complete informed consent process
- \<13 or > 65 years of age for PS, >13 for AD and NA
- AD subjects: disease without upper extremity, lower extremity, or trunk lesions
- AD subjects: total disease severity less than moderate (EASI \<12), depending on enrollment
- PS subjects: disease without upper extremity, lower extremity, or trunk lesions
- PS subjects: total disease severity less than moderate (PASI \<7), depending on enrollment
- Control subjects: diagnosed with an inflammatory skin disease
- Severe concomitant illness(es) that, in the investigator's judgment, would adversely affect the individual's participation in the study (Ex: HIV infection, autoimmune disease, severe heart failure, Hx of malignancy (other than in situ cervical cancer or basosquamous skin cancer), etc.)
- Recent bacterial, fungal, or viral infection requiring systemic therapies (PO, IV or IM) within the last month.
- Subjects with a history of serious life-threatening reaction to tape or adhesives may be enrolled but cannot undergo Tape stripping procedure and will therefore only have a baseline TEWL measurement.
- (For Skin biopsy substudy only) - Subjects with history of keloid formation or allergy to lidocaine.
Recruiting US locations
University of Rochester Medical Center
Rochester, NY 14642
Site contact: Lisa Beck, MD · 585-275-7546 · lisa_beck@urmc.rochester.edu
Study contacts (from the official record)
- Dermatology clinical trials unit · 585-273-4195 · DermCTU_Appointments@URMC.Rochester.edu
Similar studies in New York
All dermatology studies in New York →- RecruitingHealthy volunteersPhase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Bambusa Therapeutics
- Location
- New York, NY + 2 other US sites
- Eligibility basics
- Ages 18–72
- RecruitingHealthy volunteers
Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
Lumenis Be Ltd.
- Location
- New York, NY
- Eligibility basics
- Ages 21–55
- RecruitingHealthy volunteers
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Pfizer
- Location
- New York, NY
- Eligibility basics
- Ages 0 mo+ · Women only
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- New York, NY + 22 other US sites
- Eligibility basics
- Ages 18+